Home > Insider Trading > Filing (0001209191-16-095841)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610876	Jeffrey Chodakewitz	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp Gmda, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-02-02	14,416	$0.01	114,978	No	4	A	Direct
Common Stock	Disposition	2016-02-02	1,100	$90.89	113,878	No	4	S	Direct
Common Stock	Disposition	2016-02-02	1,275	$91.80	112,603	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Acquisiton	2016-02-02	28,735	$0.00	28,735	$91.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,735		2026-02-01	No	4	A	Direct

Footnotes

Restricted stock unit award that vests in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019.
Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1.
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $90.89 (range $90.49 to $91.33).
Open market sales reported on this line occurred at a weighted average price of $91.80 (range $91.56 to $92.36).
The option vests in 16 quarterly installments from 02/02/2016.